Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs Effecty

Eden
Site position #16

Lower grade

Effecty
Site position #21

Higher grade

The verdict

Effecty takes it — 83.7/100 to 81.6/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEden +5
85
80
Dose & formulationEden +2
86
84
Clinical oversightEffecty +30
55
85
Labs & monitoringEden +8
92
84
FulfillmentEden +6
93
87
Contract termsEden +4
90
86
Eden · top barEffecty · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenEffecty
WeighScore81.6/10083.7/100
GradeB−B
Site position#16#21
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkout$160/mo
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkout$240/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
Effecty

Site position #21 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

What to consider

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard